The Latest Cardiac and Vascular News
TEL AVIV, Israel, Sept. 8, 2020 /PRNewswire/ — MedHub Ltd, a medical technology company specializing in the development and commercialization of AI powered technologies that aid in the diagnosis of cardiac disease, announced today the appointment of Prof. Rafael Beyar as the Chairman of the company’s Board of Directors. As MedHub continues to execute on its go-to-market […]
PASADENA, Calif.–(BUSINESS WIRE)–Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that the board of directors appointed veteran pharmaceutical industry executive Oye Olukotun, M.D., MPH, as an independent director of the company, with a term beginning effective September 1, 2020. Douglass Given, M.D., Ph.D., Chairman of the Board of Arrowhead, said, “Oye […]
Company to use non-dilutive capital for working capital, M&A, investment in technology SANTA MONICA, Calif.–(BUSINESS WIRE)–Ontrak, Inc. (NASDAQ: OTRK) (“Ontrak” or the “Company”), a leading AI-powered and telehealth enabled, virtualized outpatient healthcare treatment company, today announced that it has closed the full exercise of the underwriters’ over-allotment option regarding its previously announced […]
Vancouver, BC, Canada, Sept. 03, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) is pleased to announce the results of the votes on matters considered at its Annual General Meeting of Shareholders held on September 3, 2020 in Vancouver, B.C. (the “Meeting”). […]
CARLSBAD, Calif., Sept. 03, 2020 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), today announced it will release its financial results for the second quarter of 2020 after market close on Thursday, September 17, 2020. In conjunction with the release, Acutus will host a conference call and webcast at […]
Press release Malmö, Sweden September 3, 2020 Acarix publishes a supplement to the prospectus The board of directors of Acarix AB (“Acarix” or the “Company”) has prepared a supplement to the prospectus regarding invitation to acquire shares in the approved preferential rights issue in Acarix which was approved by the […]
DUBLIN, Ireland and BRIDGEWATER, N.J., Sept. 03, 2020 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) today provided an update following the decision by the U.S. Court of Appeals for the Federal Circuit in the company’s ongoing patent litigation. The Court upheld the March ruling by the U.S. District Court for […]
ENGLEWOOD, Colo., Sept. 3, 2020 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced order growth for July and August 2020. Aggregate orders in July and August were 83% above the prior […]
Funding to advance “home hospital” initiatives with health systems and “beyond the pill” digital therapeutics partnerships with pharmaceutical companies BOSTON, Sept. 3, 2020 /PRNewswire/ — Biofourmis, a fast-growing global leader in digital therapeutics that powers personalized predictive care, has announced the completion of a $100 million Series C financing round led by SoftBank Vision Fund […]
ATLANTA, Sept. 2, 2020 /PRNewswire/ — CryoLife, Inc. (“CryoLife”;NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has acquired Ascyrus Medical LLC (Ascyrus). Ascyrus is a Florida-based, privately-held developer of the Ascyrus Medical Dissection Stent (AMDS™), the world’s first aortic arch remodeling device used for the […]
